Pharmaceutical formulation

Results: 107



#Item
71GDUFA User Fee Payments Or: How to Get It Wrong Donal Parks, Director Division of User Fee Management & Budget Formulation US FDA / CDER / OM

GDUFA User Fee Payments Or: How to Get It Wrong Donal Parks, Director Division of User Fee Management & Budget Formulation US FDA / CDER / OM

Add to Reading List

Source URL: www.fda.gov

Language: English
72Interpretation of "Identical Medicinal Ingredient" - Questions and Answers

Interpretation of "Identical Medicinal Ingredient" - Questions and Answers

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-07-12 14:25:51
73A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly OralDosage Forms

A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly OralDosage Forms

Add to Reading List

Source URL: bpca.nichd.nih.gov

Language: English - Date: 2014-08-18 15:07:18
74DEPARTMENT OF HEALTH St HUMAN SERVICES Foodand Drug Administration Rockville M D[removed]NADA[removed]Ann Hokinson, Assistant Manager, PharmaceuticalRegulatory Affairs

DEPARTMENT OF HEALTH St HUMAN SERVICES Foodand Drug Administration Rockville M D[removed]NADA[removed]Ann Hokinson, Assistant Manager, PharmaceuticalRegulatory Affairs

Add to Reading List

Source URL: www.fda.gov

Language: English
75Medicine / Clinical research / Food and Drug Administration / Drug Master File / Pharmaceutical formulation / Excipient / Dosage form / Abbreviated New Drug Application / Clinical trial / Pharmacology / Pharmaceutical sciences / Pharmaceutical industry

Therapeutic Products Directorate

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-06-24 11:39:20
76Clinical research / Pharmaceutics / Research / Drug Master File / Pharmaceutical formulation / Excipient / Dosage form / Validation / Good manufacturing practice / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology

Therapeutic Products Directorate To: [Name], Director, Office of Clinical Trials

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-06-24 11:39:21
77Clinical research / Pharmaceutics / Pharmaceuticals policy / Food and Drug Administration / Drug Master File / Pharmaceutical formulation / Excipient / Dosage form / Validation / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology

Therapeutic Products Directorate To: [Name], Director, Office of Clinical Trials

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-06-24 11:39:20
78Microsoft Word - qoscecta_sgqecdec_ph_iii-eng.doc

Microsoft Word - qoscecta_sgqecdec_ph_iii-eng.doc

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-07-12 14:26:07
79Quality Overall Summary - Chemical Entities, Clinical Trial Application - Phase I

Quality Overall Summary - Chemical Entities, Clinical Trial Application - Phase I

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-07-12 14:26:07
80Microsoft Word - qoscecta_sgqecdec_ph_ii-eng.doc

Microsoft Word - qoscecta_sgqecdec_ph_ii-eng.doc

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-07-12 14:26:07